US 2016/0106746 A1Published application

Pharmaceutical formulations for treating ocular conditions

AssigneeOyster Point Pharma, Inc.

InventorsDouglas Michael ACKERMANN, JR., James LOUDIN, Kenneth J. MANDELL

Life of this patent

Estimating the term…

Abstract

Described herein are pharmaceutical formulations for treating ocular conditions.

Claims20

Dependent claims

A pharmaceutical formulation for local administration into the nasal cavity of an individual comprising a nicotinic acetylcholine receptor agonist formulated (a) for nasal administration and (b) to prevent desensitization.

Dependencies are inferred from the claim text.

Facts

Application: 14/887,259Filed 19 Oct 2015
Priority: 20 Oct 2014
Published: 21 Apr 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 31/4995
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrazines or piperazines…
A61K 9/0043
Galenical forms characterised by the site of application: nose
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 9/007
Galenical forms characterised by the site of application: pulmonary tract; Aromatherapy

Family

Application62/066,280Us provisional application · filed 20 Oct 2014
Application62/100,844Us provisional application · filed 7 Jan 2015
US 9,504,645 B2Related patent
US 2016/0106746 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results